Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies (original) (raw)

SARS-CoV-2 Infections in the World: An Estimation of the Infected Population and a Measure of How Higher Detection Rates Save Lives

Carlos Luis Cubillo Villalobos

Frontiers in Public Health, 2020

View PDFchevron_right

Evaluation of the risk of SARS-CoV-2 infection and hospitalization in vaccinated and previously infected subjects based on real world data

Fabrizio Faggiano

Scientific Reports, 2023

View PDFchevron_right

Methodological Problems and Solutions for Sampling in Epidemiological SARS-CoV-2 Research Comment

Dr. Julia Bartosch

Survey research methods, 2020

View PDFchevron_right

Brief Facts about COVID-19 (SARS-CoV-2)

Sorush Niknamian

Journal of Surgery Research and Practice, 2021

View PDFchevron_right

Interaction between SARS-CoV-2 and human organism

Valentin Cebotarescu

2020

View PDFchevron_right

Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

Karina-Doris Vihta

New England Journal of Medicine, 2021

View PDFchevron_right

Use of a bioinformatic tool for the molecular epidemiology of SARS-COV-2

Sebastian Iglesias-Osores

2020

View PDFchevron_right

SARS-CoV-2 Systemic Effects: New Clues

daria bortolotti

Microorganisms, 2023

View PDFchevron_right

Long term persistence of coronavirus SARS-CoV-2 infection

Ketti Oliveira

Einstein (São Paulo)

View PDFchevron_right

Some Recent Facts about SARS-CoV-2

Dr. Parul Thapar

Acta Scientific Microbiology, 2020

View PDFchevron_right

Advancement of SARS-CoV-2 infection in children

fuyong jiao

Pediatria polska, 2021

View PDFchevron_right

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020

Aron Hall

JAMA Internal Medicine, 2020

View PDFchevron_right

High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia

haleema alserehi

Infection, 2021

View PDFchevron_right

Diagnostics for SARS-CoV-2 infections

NEHA BAJWA

Nature Materials, 2021

View PDFchevron_right

Tribulations of the Sars-Cov-2 over the Globe

ilai goshen

Scholars Journal of Applied Medical Sciences, 2020

View PDFchevron_right

High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!

Percy Mayta-Tristan

International Journal of Infectious Diseases, 2021

View PDFchevron_right

Predictors for Severity of SARS-CoV-2 Infection Among Healthcare Workers

mohamed elbadry

Journal of Multidisciplinary Healthcare, 2021

View PDFchevron_right

Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults

shreya jha

JAMA Network Open, 2022

View PDFchevron_right

SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective

Maria Anice Mureb Sallum

Infection, Genetics and Evolution, 2020

View PDFchevron_right

SARS-CoV-2 epidemiology and control, different scenarios for Turkey

Deniz Gökengin

TURKISH JOURNAL OF MEDICAL SCIENCES, 2020

View PDFchevron_right

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

Amin Manna

JAMA Network Open, 2021

View PDFchevron_right

SARS-CoV-2 Spread, Detection, and Dynamics in a Megacity in Latin America

Alejandro Gaviria

SSRN Electronic Journal, 2021

View PDFchevron_right

Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August–October 2020

Sonali Sarkar

Emerging Infectious Diseases, 2021

View PDFchevron_right

Evaluation of Treatment of Patients with SARS-CoV-2 in line with Literature

Çağatay ONAR

Maltepe Tıp Dergisi, 2020

View PDFchevron_right

Using in vivo animal models for studying SARS-CoV-2

Norman A Ratcliffe

Expert Opinion on Drug Discovery, 2021

View PDFchevron_right

A Comprehensive Study of SARS-CoV-2:From 2019-nCoV to COVID-19 Outbreak

Abdul Baset

Microbiology and Biotechnology Letters, 2020

View PDFchevron_right

Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity

Isobel Routledge

Emerging Infectious Diseases

View PDFchevron_right

A cross‐sectional community‐based observational study of asymptomatic SARS‐CoV‐2 prevalence in the greater Indianapolis area

iris goetz

Journal of Medical Virology, 2020

View PDFchevron_right

Are we now observing an increasing number of coinfections between SARS‐CoV‐2 and other respiratory pathogens?

Kovy Arteaga Livias

Journal of Medical Virology, 2020

View PDFchevron_right

Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States

Isabelle Derrendinger

Emerging Infectious Diseases, 2022

View PDFchevron_right

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

Hira Imeri

PLOS Medicine

View PDFchevron_right

Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform

Usha Kiran Rout

Journal of Clinical Laboratory Analysis, 2021

View PDFchevron_right

Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients

hafsa Aziz

Viral Immunology, 2022

View PDFchevron_right

Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand

Susan Jack

Clinical & Translational Immunology

View PDFchevron_right

Impact of SARS-CoV-2 exposure history on the T cell and IgG response

Marius Tincho

Cell reports medicine, 2023

View PDFchevron_right